Details
Title
Real-world outcomes of ibrutinib therapy in Korean patients with relapsed or refractory mantle cell lymphoma: a multicenter, retrospective analysis
Author
Jun Ho Yi 1
; Seok Jin Kim 2 ; Yoon, Dok Hyun 3 ; Suh, Cheolwon 3 ; Chang, Myung Hee 4 ; Yang, Deok Hwan 5 ; Jae-Cheol, Jo 6 ; Shin Young Hyun 7 ; Hyeon-Seok Eom 8 ; Jeong-Ok, Lee 9 ; Kwon, Ji Hyun 10 ; Han, Sang Hoon 11 ; Seung-Shin, Lee 12
; Jae-Yong Kwak 13 ; Se Hyung Kim 14 ; Kim, Dae Sik 15 ; Lee, Ji Hyun 16 ; Sung Yong Oh 16 ; Ryoo, Hun Mo 17 ; Hyo Jung Kim 18 ; Kim, Won Seog 2
1 Division of Hematology-Oncology, Department of Medicine, Chung-Ang University, Dongjak-gu, Seoul, Korea
2 Division of Hematology and Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Gangnam-gu, Seoul, Korea
3 Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Songpa-gu, Seoul, Korea
4 National Health Insurance Corporation Ilsan Hospital, Ilsandong-gu, Goyang, Korea
5 Department of Hemato-Oncology, Chonnam National University Hwasun Hospital, Chonnam National University Medical School, Hwasun, Gwangju, Korea
6 Department of Hematology and Oncology, Ulsan University Hospital, University of Ulsan College of Medicine, Dong-gu, Ulsan, Korea
7 Department of Internal Medicine, Yonsei University Wonju College of Medicine, Gangwon-Do, Wonju, Korea
8 Department of Internal Medicine, National Cancer Center, Goyang-si Gyeonggi-do, Goyang, Korea
9 Department of Internal Medicine, Seoul National University Bundang Hospital, Bundang-gu, Seongnam, Korea
10 Department of Internal Medicine, ChungBuk National University Hospital, Chungbuk, Cheongju, Korea
11 Department of Internal Medicine, Jeju National University Hospital, Jeju National University School of Medicine, Jeju, Korea
12 Department of Hematology-Oncology, Wonkwang University Hospital, Iksan-daero, Iksan, Korea
13 Department of Internal Medicine, Jeonbuk National University Medical School, Jeollabuk-do, Jeonju, Korea
14 Division of Hematology-Oncology, Department of Internal Medicine, Soonchunhyang University, College of Medicine, Bucheon Hospital, Wonmi-gu, Bucheon, Korea
15 Division of Hematology-Oncology, Department of Internal Medicine, Korea University Guro Hospital, Guro-gu, Seoul, Korea
16 Division of Hematology-Oncology, Department of Internal Medicine, Dong-A University College of Medicine, Seo-gu, Busan, Korea
17 Department of Internal Medicine, Division of Hematology-Oncology, Catholic University of Daegu, Daegu, Korea
18 Division of Hematology-Oncology, Department of Internal Medicine, Hallym University Sacred Heart Hospital, Hallym University College of Medicine, Dongan-gu, Anyang, Korea
; Seok Jin Kim 2 ; Yoon, Dok Hyun 3 ; Suh, Cheolwon 3 ; Chang, Myung Hee 4 ; Yang, Deok Hwan 5 ; Jae-Cheol, Jo 6 ; Shin Young Hyun 7 ; Hyeon-Seok Eom 8 ; Jeong-Ok, Lee 9 ; Kwon, Ji Hyun 10 ; Han, Sang Hoon 11 ; Seung-Shin, Lee 12
; Jae-Yong Kwak 13 ; Se Hyung Kim 14 ; Kim, Dae Sik 15 ; Lee, Ji Hyun 16 ; Sung Yong Oh 16 ; Ryoo, Hun Mo 17 ; Hyo Jung Kim 18 ; Kim, Won Seog 2 1 Division of Hematology-Oncology, Department of Medicine, Chung-Ang University, Dongjak-gu, Seoul, Korea
2 Division of Hematology and Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Gangnam-gu, Seoul, Korea
3 Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Songpa-gu, Seoul, Korea
4 National Health Insurance Corporation Ilsan Hospital, Ilsandong-gu, Goyang, Korea
5 Department of Hemato-Oncology, Chonnam National University Hwasun Hospital, Chonnam National University Medical School, Hwasun, Gwangju, Korea
6 Department of Hematology and Oncology, Ulsan University Hospital, University of Ulsan College of Medicine, Dong-gu, Ulsan, Korea
7 Department of Internal Medicine, Yonsei University Wonju College of Medicine, Gangwon-Do, Wonju, Korea
8 Department of Internal Medicine, National Cancer Center, Goyang-si Gyeonggi-do, Goyang, Korea
9 Department of Internal Medicine, Seoul National University Bundang Hospital, Bundang-gu, Seongnam, Korea
10 Department of Internal Medicine, ChungBuk National University Hospital, Chungbuk, Cheongju, Korea
11 Department of Internal Medicine, Jeju National University Hospital, Jeju National University School of Medicine, Jeju, Korea
12 Department of Hematology-Oncology, Wonkwang University Hospital, Iksan-daero, Iksan, Korea
13 Department of Internal Medicine, Jeonbuk National University Medical School, Jeollabuk-do, Jeonju, Korea
14 Division of Hematology-Oncology, Department of Internal Medicine, Soonchunhyang University, College of Medicine, Bucheon Hospital, Wonmi-gu, Bucheon, Korea
15 Division of Hematology-Oncology, Department of Internal Medicine, Korea University Guro Hospital, Guro-gu, Seoul, Korea
16 Division of Hematology-Oncology, Department of Internal Medicine, Dong-A University College of Medicine, Seo-gu, Busan, Korea
17 Department of Internal Medicine, Division of Hematology-Oncology, Catholic University of Daegu, Daegu, Korea
18 Division of Hematology-Oncology, Department of Internal Medicine, Hallym University Sacred Heart Hospital, Hallym University College of Medicine, Dongan-gu, Anyang, Korea
Pages
275-278
Section
LETTERS TO THE EDITOR
Publication year
2021
Publication date
Mar 2021
e-ISSN
2523-3548
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2702741331
Copyright
© 2021. This work is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.